Justin Kim Stock Analyst Profile - Oppenheimer Research Coverage - Stocknear

Justin Kim

Stock Analyst at Oppenheimer

(3.93)
# 2093
Out of 5,506 analysts
44
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

13 Stocks

Name Action PT Current % Upside Ratings Updated
ZURA Zura Bio
Maintains: Outperform
17 16
3.93 307.12% 2 Aug 15, 2025
APLS Apellis Pharmaceutic...
Maintains: Outperform
65 40
23.8 68.07% 6 Nov 6, 2024
PHVS Pharvaris
Maintains: Outperform
38 42
23.39 79.56% 4 Sep 6, 2024
CYTK Cytokinetics
Maintains: Outperform
107 106
56.97 86.06% 5 May 9, 2024
IMCR Immunocore Hldgs
Reiterates: Outperform
85 87
34.21 154.31% 5 Feb 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
26
30.14 -13.74% 1 Jan 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Oct 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
33 34
n/a n/a 2 Feb 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
14 18
n/a n/a 3 Nov 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 6 Nov 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 4 Aug 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
59
69.15 -14.68% 1 Jul 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 3 Jun 30, 2022